Apricot Capital

Activity in this selectiontalon-capital-9979ae6f

By stage

Series A3

Seed1

Biotech4

China4

4 in this selection

Apr 29

Develops in vivo CAR-T cell therapies for cancer and autoimmune diseases

$50MSeries A+

Role not disclosed

Apr 10

Develops extrahepatic RNA-targeting therapeutics

$54MSeries A

Role not disclosed

Mar 18

Develops next-generation T-cell engager therapies for cancer and autoimmune diseases

Role not disclosed

Jan 12

Develops intelligent, logic-gated therapeutics for solid tumors

$61MSeries A

Role not disclosed